Literature DB >> 9112589

Sensory neuropathies including painful and toxic neuropathies.

J H Wokke1, G W van Dijk.   

Abstract

In most peripheral neuropathies, dysfunction of motor and sensory nerve fibres is present. However, in some of them either pattern may predominate or be exclusively present. In this review we describe the clinical characteristics of sensory neuropathies, with emphasis on their possible causes. Guidelines are given for the diagnostic approach in these patients and, where possible, suggestions are given for treatment, including symptomatic treatment of painful neuropathies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9112589     DOI: 10.1007/s004150050075

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  69 in total

1.  The effect of vitamin B6 deficiency induced by desoxypyridoxine in human beings.

Authors:  R W VILTER; J F MUELLER; H S GLAZER; T JARROLD; J ABRAHAM; C THOMPSON; V R HAWKINS
Journal:  J Lab Clin Med       Date:  1953-09

2.  Subacute sensory neuronopathy secondary to dorsal root ganglionitis in primary Sjögren's syndrome.

Authors:  K Malinow; G D Yannakakis; S M Glusman; D W Edlow; J Griffin; A Pestronk; D L Powell; R Ramsey-Goldman; B H Eidelman; T A Medsger
Journal:  Ann Neurol       Date:  1986-10       Impact factor: 10.422

3.  Tendon reflex asymmetry by voluntary mental effort in healthy subjects.

Authors:  J Stam; H D Speelman; H van Crevel
Journal:  Arch Neurol       Date:  1989-01

4.  An improved automated method for the measurement of thermal thresholds. 1. Normal subjects.

Authors:  G A Jamal; S Hansen; A I Weir; J P Ballantyne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-04       Impact factor: 10.154

5.  The origin of fasciculations.

Authors:  G Roth
Journal:  Ann Neurol       Date:  1982-12       Impact factor: 10.422

6.  Peripheral neuropathy in primary Sjögren's syndrome.

Authors:  S I Mellgren; D L Conn; J C Stevens; P J Dyck
Journal:  Neurology       Date:  1989-03       Impact factor: 9.910

7.  Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy.

Authors:  W Q Gao; N Dybdal; N Shinsky; A Murnane; C Schmelzer; M Siegel; G Keller; F Hefti; H S Phillips; J W Winslow
Journal:  Ann Neurol       Date:  1995-07       Impact factor: 10.422

8.  Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities.

Authors:  N C Notermans; J H Wokke; H M Lokhorst; H Franssen; Y van der Graaf; F G Jennekens
Journal:  Brain       Date:  1994-12       Impact factor: 13.501

9.  The clinical features of hereditary motor and sensory neuropathy types I and II.

Authors:  A E Harding; P K Thomas
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

10.  Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies.

Authors:  V Chaudhry; E K Rowinsky; S E Sartorius; R C Donehower; D R Cornblath
Journal:  Ann Neurol       Date:  1994-03       Impact factor: 10.422

View more
  3 in total

1.  Diagnostic investigation of patients with chronic polyneuropathy: evaluation of a clinical guideline.

Authors:  N R Rosenberg; P Portegies; M de Visser; M Vermeulen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-08       Impact factor: 10.154

2.  Diagnostic work-up in peripheral neuropathy: an analysis of 171 cases.

Authors:  D Lubec; W Müllbacher; J Finsterer; B Mamoli
Journal:  Postgrad Med J       Date:  1999-12       Impact factor: 2.401

3.  Neurotrimin is an estrogen-regulated determinant of peripheral sympathetic innervation.

Authors:  Dora Krizsan-Agbas; Tetyana Pedchenko; Peter G Smith
Journal:  J Neurosci Res       Date:  2008-11-01       Impact factor: 4.164

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.